How does Onconomics work?
Being a drug efficacy test, this test analyzes the effectiveness of various chemotherapeutic agents on your specific cancer cells, creating a personalized profile to guide treatment.
The Onconomics test employs a dual approach, combining molecular and cellular methods to assess the effectiveness of various cancer therapies.
The process involves the isolation of malignant cells through Fluorescence-activated Cell Sorting (FACS) and negative selection. Then it is followed by epigenetic analysis and viability assays which determine how well specific treatments can suppress cancer.
The isolated cells are then expanded and divided into two groups: one set undergoes viability assays, while the other is subjected to transcriptomic microarrays which assess the genetic and genomic profile.